Effect of Krishnavajrabhraka Bhasma [KVB] in Asthma

Not Applicable

Completed

• Conditions: Health Condition 1: null- Chronic bronchial Asthma

• Registration Number: CTRI/2018/04/013084
• Lead Sponsor: Department of Indian System of Medicine Homoepathy AYUSH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2008-09-22
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 41

Inclusion Criteria

I Ayurvedic parameters

•Patients presenting with signs and symptoms of Tamak Shwas for equal to and more than one year as described in Ayurvedic texts.

•Patients presenting with 3 or more of the following symptoms-

i. Peenasii. Ghurghurak

iii. Aasya Udhvanasa iv. Kantha Udhvansav.Vak Kricchratavi. Lalat Sweda

vii. Parshvagrahaviii. Ushnabhiprayataix. Aasya Shushkata x. Vepathu xi. Aruchixii. Annadvesh

II Modern medicine parameters

Patients with bronchial asthma categorised as

mild intermittent

mild persistant

moderate persistant

Exclusion Criteria

I Ayurvedic Parameters

•Patients in whom â??Shwasâ?? is present as a Upadrava, Lakshan , Udarka, Poorvaroop and Arishta lakshan of other disease.

•Patients in whom the onset of disease is less than one year

•Patients with Shwas caused due to fatal injury of Urasthita Marma (Stanmool, Stanrohit, Aapalaap, Aapsthambh).

•Patients with critical condition of Shwas.

•Patients with Shwas which requires Shodhan such as Virechan or Vaman for therapeutic use

II Modern medicine parameters

Cases with co-existing pulmonary conditions.

Acute respiratory tract infection.

Requiring oral steroids.

Pregnant and lactating women

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
I-To assess improvement in Spirometric indices FEV1 by _ 200ml. <br/ ><br>II-Reduction in the number of acute attacks <br/ ><br> <br/ ><br>Reducing in the number of acute attacks. <br/ ><br>Timepoint: 9 months <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
Increase in duration between two consecutive acute attacks <br/ ><br> <br/ ><br>Decrease in severity of the attack <br/ ><br> <br/ ><br>Reduction in number of puffs per day <br/ ><br> <br/ ><br>Improvement in values of Peak flow meter <br/ ><br> <br/ ><br>Improvement in asthma symptom score throughout daytime point <br/ ><br>Timepoint: 9 months